Biography and Research Information
OverviewAI-generated summary
John Gillenwater studies the role of SIRT2 in the progression of murine melanoma. His research investigates how SIRT2 influences natural killer (NK) cell activity, a critical component of the immune system's defense against cancer. Gillenwater's work has demonstrated that SIRT2 promotes melanoma growth by inhibiting NK cells. He has published research on this topic, with his most recent publication appearing in 2021. Gillenwater collaborates with researchers at the University of Arkansas for Medical Sciences, including Mousumi Patra, Fen Xia, and Wuying Du. He has a h-index of 3, with 6 total publications and 48 citations.
Metrics
- h-index: 3
- Publications: 6
- Citations: 48
Selected Publications
-
SIRT2 Promotes Murine Melanoma Progression Through Natural Killer Cell Inhibition (2021)
-
SIRT2 promotes murine melanoma progression through natural killer cell inhibition (2021)
Collaboration Network
Top Collaborators
- SIRT2 promotes murine melanoma progression through natural killer cell inhibition
- SIRT2 Promotes Murine Melanoma Progression Through Natural Killer Cell Inhibition
- OC-0182 SIRT2 promotes murine melanoma progression through natural killer cell inhibition
- SIRT2 promotes murine melanoma progression through natural killer cell inhibition
- SIRT2 Promotes Murine Melanoma Progression Through Natural Killer Cell Inhibition
- SIRT2 promotes murine melanoma progression through natural killer cell inhibition
- SIRT2 Promotes Murine Melanoma Progression Through Natural Killer Cell Inhibition
- SIRT2 promotes murine melanoma progression through natural killer cell inhibition
- SIRT2 promotes murine melanoma progression through natural killer cell inhibition
- SIRT2 promotes murine melanoma progression through natural killer cell inhibition
- SIRT2 promotes murine melanoma progression through natural killer cell inhibition
- SIRT2 promotes murine melanoma progression through natural killer cell inhibition
- OC-0182 SIRT2 promotes murine melanoma progression through natural killer cell inhibition
- OC-0182 SIRT2 promotes murine melanoma progression through natural killer cell inhibition
- OC-0182 SIRT2 promotes murine melanoma progression through natural killer cell inhibition
- OC-0182 SIRT2 promotes murine melanoma progression through natural killer cell inhibition
- OC-0182 SIRT2 promotes murine melanoma progression through natural killer cell inhibition
- SIRT2 Promotes Murine Melanoma Progression Through Natural Killer Cell Inhibition
- SIRT2 Promotes Murine Melanoma Progression Through Natural Killer Cell Inhibition
Similar Researchers
Based on overlapping research topics